scholarly journals A multi-centre randomized, open-label phase II trial of continuous erlotinib plus gemcitabine or gemcitabine as first-line therapy in ECOG PS2 patients with advanced non-small cell lung cancer

2012 ◽  
Vol 28 (3) ◽  
pp. 763-767 ◽  
Author(s):  
M. MICHAEL ◽  
N. PAVLAKIS ◽  
P. CLINGAN ◽  
R. DE BOER ◽  
M. JOHNSTON ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Open Label ◽  
First Line Therapy ◽  
Line Therapy ◽  
Open Label Phase

Phase II Trial of Irinotecan plus Cisplatin Combination as First Line Therapy for Patients with Small cell Lung Cancer

2006 ◽  
Vol 60 (1) ◽  
pp. 57 ◽  
Author(s):  
Hye Cheol Jeong ◽  
Sang Yeub Lee ◽  
Jung Ha Kim ◽  
Eun Sil Ha ◽  
Jin Yong Jung ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Phase II trial of docetaxel and gefitinib as first-line therapy for elderly patients with advanced non-small cell lung cancer (ANSCLC)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7342-7342
Author(s):  
C. C. Williams ◽  
E. B. Haura ◽  
S. J. Antonia ◽  
A. Chiappori ◽  
G. Bepler ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Phase II trial of docetaxel and gefitinib as first-line therapy for elderly patients with advanced non-small cell lung cancer (ANSCLC)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7342-7342 ◽  
Author(s):  
C. C. Williams ◽  
E. B. Haura ◽  
S. J. Antonia ◽  
A. Chiappori ◽  
G. Bepler ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document